As more drug and device startups outsource development work, demand for wet lab space has declined, said BioStart President Carol Frankenstein. Currently, 18 companies are occupying 65 percent of BioStart’s available space.
The company currently has $500,000 in funding to parcel out. Since it started in 1996, BioStart has helped 125 med-tech companies launch and raise a total of $180 million.
Read the MedCity report on BioStart.
Related Articles on Medical Device Start-ups:
Nevro Raises $58M to Prepare Spinal Cord Stimulator for U.S. Launch
Device Publication Names Five Most Innovative CEOs
Report Calls for Less Complexity in Medical Device Design
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
